van Eijck CH - Search Results

1

The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors.

van Eijck CH, Lamberts SW, Lemaire LC, Jeekel H, Bosman FT, Reubi JC, Bruining HA, Krenning EP. van Eijck CH, et al. Ann Surg. 1996 Aug;224(2):119-24. doi: 10.1097/00000658-199608000-00002. Ann Surg. 1996. PMID: 8757373 Free PMC article.

2

111In-octreotide scintigraphy in oncology.

Krenning EP, Kwekkeboom DJ, Reubi JC, Van Hagen PM, van Eijck CH, Oei HY, Lamberts SW. Krenning EP, et al. Among authors: van hagen pm, van eijck ch. Metabolism. 1992 Sep;41(9 Suppl 2):83-6. doi: 10.1016/0026-0495(92)90038-c. Metabolism. 1992. PMID: 1355591 Review.

3

Role of tumor-derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotide.

Hofland LJ, van der Burg B, van Eijck CH, Sprij DM, van Koetsveld PM, Lamberts SW. Hofland LJ, et al. Among authors: van koetsveld pm, van eijck ch, van der burg b. Int J Cancer. 1995 Jan 3;60(1):93-9. doi: 10.1002/ijc.2910600114. Int J Cancer. 1995. PMID: 7529213 Free article.

4

Somatostatin-receptor scintigraphy in primary breast cancer.

van Eijck CH, Krenning EP, Bootsma A, Oei HY, van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SW. van Eijck CH, et al. Among authors: van pel r. Lancet. 1994 Mar 12;343(8898):640-3. doi: 10.1016/s0140-6736(94)92637-9. Lancet. 1994. PMID: 7906813 Free article.

5

Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide.

van Eijck CH, Slooter GD, Hofland LJ, Kort W, Jeekel J, Lamberts SW, Marquet RL. van Eijck CH, et al. Br J Surg. 1994 Sep;81(9):1333-7. doi: 10.1002/bjs.1800810925. Br J Surg. 1994. PMID: 7953404

6

111In-octreotide scintigraphy in oncology.

Krenning EP, Kwekkeboom DJ, Reubi JC, van Hagen PM, van Eijck CH, Oei HY, Lamberts SW. Krenning EP, et al. Among authors: van hagen pm, van eijck ch. Digestion. 1993;54 Suppl 1:84-7. doi: 10.1159/000201083. Digestion. 1993. PMID: 8359573

7

Serum CA19-9 determination in the management of pancreatic cancer.

van den Bosch RP, van Eijck CH, Mulder PG, Jeekel J. van den Bosch RP, et al. Among authors: van eijck ch. Hepatogastroenterology. 1996 May-Jun;43(9):710-3. Hepatogastroenterology. 1996. PMID: 8799418

8

Nuclear medicine imaging of breast cancer.

Van Eijck CH, Krenning EP, Kvols LK. Van Eijck CH, et al. Nucl Med Commun. 1996 Nov;17(11):925-7. doi: 10.1097/00006231-199611000-00001. Nucl Med Commun. 1996. PMID: 8971862 Review. No abstract available.

9

Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer.

Bonjer HJ, Bruining HA, Pols HA, de Herder WW, van Eijck CH, Breeman WA, Krenning EP. Bonjer HJ, et al. Among authors: van eijck ch. Eur J Nucl Med. 1997 Mar;24(3):246-51. doi: 10.1007/BF01728759. Eur J Nucl Med. 1997. PMID: 9143460

10

Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells.

van den Tol PM, van Rossen EE, van Eijck CH, Bonthuis F, Marquet RL, Jeekel H. van den Tol PM, et al. Among authors: van rossen ee, van eijck ch. Ann Surg. 1998 Feb;227(2):242-8. doi: 10.1097/00000658-199802000-00014. Ann Surg. 1998. PMID: 9488523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters